BUWA.STU Bio-Rad Laboratories Inc
- Market cap
- -
- P/E
- 47.6x
- P/B
- 1.42x
- ROE
- -4.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is BUWA.STU undervalued?
Graham numberThe Graham number of Bio-Rad Laboratories Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Bio-Rad Laboratories Inc fundamental analysis
No fundamental analysis for Bio-Rad Laboratories Inc yet.
Bio-Rad Laboratories Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Bio-Rad Laboratories Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Bio-Rad Laboratories Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 2.29B | 2.29B | 2.55B | 2.92B | 2.80B | 2.67B | 2.57B | 2.58B | 2.49B |
| Gross Profit | 1.22B | 1.25B | 1.44B | 1.64B | 1.57B | 1.43B | 1.38B | 1.34B | 1.31B |
| Operating Income | 189M | 243M | 421M | 500M | 475M | 338M | 269M | 219M | 213M |
| EBITDA | 675M | 2.42B | 5.07B | 5.57B | -4.53B | -655M | -2.14B | 1.21B | -82.6M |
| Net Income | 366M | 1.95B | 3.81B | 4.25B | -3.63B | -637M | -1.84B | 760M | -311M |
| EPS | 12 | 65 | 128 | 142 | -123 | -22 | -66 | 28 | -12 |
| Balance Sheet | |||||||||
| Total Assets | 5.61B | 8.01B | 13.0B | 17.8B | 13.5B | 12.3B | 9.36B | 10.6B | 10.3B |
| Total Liabilities | 1.59B | 2.25B | 3.09B | 4.11B | 3.89B | 3.56B | 2.79B | 3.12B | 3.08B |
| Shareholders' Equity | 4.02B | 5.76B | 9.88B | 13.7B | 9.62B | 8.74B | 6.57B | 7.45B | 7.17B |
| Cash & Short-term Investments | 432M | 661M | 662M | 471M | 434M | 404M | 488M | 530M | 517M |
| Cash Flow | |||||||||
| Operating Cash Flow | 285M | 414M | 585M | 669M | 194M | 375M | 455M | 532M | 414M |
| Capital Expenditure | 130M | 92.5M | 109M | 134M | 114M | 157M | 189M | 158M | 124M |
| Free Cash Flow | 156M | 322M | 476M | 536M | 80.1M | 218M | 266M | 375M | 290M |
| Ratios | |||||||||
| ROE | 9.1% | 33.8% | 38.6% | 31.1% | -37.7% | -7.3% | -28.1% | 10.2% | -4.3% |
| ROA | 6.5% | 24.3% | 29.4% | 23.9% | -26.9% | -5.2% | -19.7% | 7.2% | -3.0% |
| Net Profit Margin | 16.0% | 84.9% | 149.8% | 145.6% | -129.5% | -23.9% | -71.9% | 29.4% | -12.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Bio-Rad Laboratories Inc dividends
Bio-Rad Laboratories Inc has not paid dividends in the last 8 fiscal years.
Who owns Bio-Rad Laboratories Inc
Ownership data of Bio-Rad Laboratories Inc is not available yet.
Bio-Rad Laboratories Inc company profile
- Company name
- Bio-Rad Laboratories Inc
- Ticker
- BUWA.STU
- Exchange
- Stuttgart Exchange
- Sector
- -
- Industry
- -
- Fiscal year end
- December
- Address
- Website
- -